CMH — Chordate Medical Holding AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK0.95m
- -SEK3.30m
- SEK0.66m
Brief: Chordate Medical Holding Says Last Day Of Trading Is In March 2026
Brief: Chordate Medical To Enter Into Voluntary Liquidation
Brief: Chordate Board Proposes AGM To Resolve On Voluntary Liquidation And Delisting
Brief: Chordate Medical Holding Q2 Net Loss SEK 5.2 Mln
Brief: Chordate Medical Adopts Cost Reduction Program For Company Sale
Brief: Chordate Decides On SEK 2.55 Mln Preference Share Placement
Brief: Chordate Medical Q1 Loss After Financial Items At SEK 5.75 Mln
Brief: Chordate Medical Appoints Additional Distributor In Saudi Arabia
Brief: Chordate Medical Receives Trademark Registration For Ozilia In U.S.
Brief: Chordate Medical Q4 Loss After Financial Items SEK 8.5 Mln
Brief: Chordate Medical Announces Outcome Of Rights Issue
Brief: Chordate Medical Holding Decides On Preferential Issue Of Around SEK 22.2 Mln
Brief: Chordate Medical Retains Swiss Advisor
Brief: Chordate Medical Gets Market Authorization For Migraine Indication
Brief: Chordate Medical Gets First Order For Ozilia Migraine Treatment From Saudi Arabia
Brief: Chordate Medical Reports Conclusions From First Data Monitoring Of Ongoing Long Term Open Study On Chronic Migraine Pm010
Brief: Chordate Medical Q2 Loss Narrows To SEK 7 Mln
Brief: Chordate Medical Gets First Order From Switzerland Worth About SEK 370,000
Brief: Chordate Enters New Partnership Agreement With Neurolite